[CTXR] YoY Quarter Result on 31-Dec-2019 [#Q1]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
13-Feb-2020
Financial Year
2020
Quarter
31-Dec-2019 [#Q1]
Profit Trend
QoQ- -18.41%
YoY- -11.54%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,450 -9,225 -8,147 -4,322 -3,875 -3,246 -2,176 7.98%
Tax 144 34 13 114 2 0 13 49.27%
NP -3,594 -9,225 -8,147 -4,322 -3,875 -3,246 -2,176 8.71%
Tax Rate - - - - - - - -
Total Cost 3,594 9,225 8,147 4,322 3,875 3,246 2,176 8.71%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.02 -0.06 -0.15 -0.15 -0.22 -0.38 -0.44 -40.24%
EPS Diluted -0.02 -0.06 -0.15 -0.15 -0.22 -0.38 -0.44 -40.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.